Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Nitrite in Children With Falciparum Malaria
NCT04289558Phase 1Withdrawn
- Sponsor
- Duke University
- Start
- Jun 2021
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of sodium nitrite in Malaria, sponsored by Duke University. Primary endpoints: Number of subjects with at least one adverse event at 48 hours and Percent change in microvascular function/activation at 48 hours. Planned start Jun 2021; status: withdrawn.
02
Drugs
sodium nitrite
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT04289558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04289558.